Janux Therapeutics, Inc. (JANX) Operating margin 2021–2025
Janux Therapeutics, Inc. (JANX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1576.7%FY2025 · since FY2021: -905.4% → -1576.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1576.7% | -643.1 pp |
| FY2024 | -933.6% | -30.7 pp |
| FY2023 | -902.9% | -123.8 pp |
| FY2022 | -779.0% | +126.3 pp |
| FY2021 | -905.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More JANX financial trends
JANX RevenueJANX Net incomeJANX Net marginJANX Gross profitJANX Gross marginJANX Operating incomeJANX Operating cash flowJANX Free cash flowJANX Capital expendituresJANX Return on equityJANX Stock buybacksJANX Dividends paidJANX Total assetsJANX Total liabilitiesJANX Shareholders’ equityJANX overview →